# Moderna, Inc.: filings

MRNA · Nasdaq · CIK 1682852 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mrna.md) · [Financials](/companies/mrna/financials.md) · [Filings](/companies/mrna/filings.md) · [Insiders](/companies/mrna/insiders.md)

## Reports and events: 161 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1018, 144 163, 8-K 113, 3 33, 10-Q 23, SC 13G/A 22, 4/A 12, DEFA14A 10, DEF 14A 9, 10-K 8, SC 13G 8, SCHEDULE 13G/A 8, S-8 6, CORRESP 5, SC TO-C 5, UPLOAD 5, 8-K/A 4, ARS 4, SCHEDULE 13G 4, 424B5 3, PX14A6G 3, S-3ASR 3, 5 2, DRS/A 2, DRSLTR 2, FWP 2, PRE 14A 2, S-1/A 2, SC TO-I/A 2, SEC STAFF LETTER 2, 10-K/A 1, 424B4 1, 8-A12B 1, CERT 1, CT ORDER 1, D 1, DRS 1, EFFECT 1, S-1 1, S-1MEF 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-30 | 11:15 ET | [8-K](/filings/0001193125-26-408289.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-408289 |
| 2026-09-01 | 20:37 ET | [8-K](/filings/0001193125-26-378505.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-378505 |
| 2026-07-31 | 20:17 ET | [10-Q](/filings/0001682852-26-000150.md) | Quarterly report, period 2026-06-30 | 0001682852-26-000150 |
| 2026-07-31 | 11:03 ET | [8-K](/filings/0001682852-26-000147.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-26-000147 |
| 2026-07-08 | 11:08 ET | [8-K](/filings/0001682852-26-000134.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-26-000134 |
| 2026-05-11 | 10:06 ET | [8-K](/filings/0001682852-26-000101.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001682852-26-000101 |
| 2026-05-01 | 20:10 ET | [10-Q](/filings/0001682852-26-000060.md) | Quarterly report, period 2026-03-31 | 0001682852-26-000060 |
| 2026-05-01 | 10:32 ET | [8-K](/filings/0001682852-26-000057.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-26-000057 |
| 2026-03-16 | 20:31 ET | [DEF 14A](/filings/0001308179-26-000081.md) | Proxy statement, period 2026-05-06 | 0001308179-26-000081 |
| 2026-03-05 | 01:20 ET | [8-K](/filings/0001682852-26-000047.md) | 1.01 Entry into a material agreement | 0001682852-26-000047 |
| 2026-02-20 | 21:02 ET | [10-K](/filings/0001682852-26-000033.md) | Annual report, period 2025-12-31 | 0001682852-26-000033 |
| 2026-02-13 | 12:02 ET | [8-K](/filings/0001682852-26-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-26-000015 |
| 2026-02-11 | 23:02 ET | [8-K](/filings/0001682852-26-000012.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001682852-26-000012 |
| 2026-01-12 | 12:01 ET | [8-K](/filings/0001682852-26-000007.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-26-000007 |
| 2026-01-05 | 14:04 ET | [8-K](/filings/0001682852-26-000003.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-26-000003 |
| 2025-11-24 | 21:29 ET | [8-K](/filings/0001628280-25-053816.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-25-053816 |
| 2025-11-20 | 12:12 ET | [8-K](/filings/0001628280-25-053318.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-053318 |
| 2025-11-13 | 21:19 ET | [8-K](/filings/0001628280-25-052055.md) | 5.07 Shareholder vote results | 0001628280-25-052055 |
| 2025-11-06 | 21:05 ET | [10-Q](/filings/0001682852-25-000075.md) | Quarterly report, period 2025-09-30 | 0001682852-25-000075 |
| 2025-11-06 | 12:03 ET | [8-K](/filings/0001682852-25-000073.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-25-000073 |
| 2025-10-15 | 12:45 ET | [DEF 14A](/filings/0001682852-25-000062.md) | Proxy statement, period 2025-11-12 | 0001682852-25-000062 |
| 2025-08-01 | 20:03 ET | [10-Q](/filings/0001682852-25-000044.md) | Quarterly report, period 2025-06-30 | 0001682852-25-000044 |
| 2025-08-01 | 11:02 ET | [8-K](/filings/0001682852-25-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-25-000041 |
| 2025-05-05 | 20:03 ET | [8-K](/filings/0001682852-25-000036.md) | 5.07 Shareholder vote results | 0001682852-25-000036 |
| 2025-05-01 | 20:02 ET | [10-Q](/filings/0001682852-25-000034.md) | Quarterly report, period 2025-03-31 | 0001682852-25-000034 |
| 2025-05-01 | 10:31 ET | [8-K](/filings/0001682852-25-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-25-000031 |
| 2025-03-11 | 20:07 ET | [DEF 14A](/filings/0001308179-25-000082.md) | Proxy statement, period 2025-04-30 | 0001308179-25-000082 |
| 2025-02-21 | 12:11 ET | [10-K](/filings/0001682852-25-000022.md) | Annual report, period 2024-12-31 | 0001682852-25-000022 |
| 2025-02-14 | 11:30 ET | [8-K](/filings/0001682852-25-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-25-000006 |
| 2025-01-13 | 12:03 ET | [8-K](/filings/0001682852-25-000002.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-25-000002 |
| 2024-11-07 | 21:03 ET | [10-Q](/filings/0001682852-24-000060.md) | Quarterly report, period 2024-09-30 | 0001682852-24-000060 |
| 2024-11-07 | 11:33 ET | [8-K](/filings/0001682852-24-000057.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-24-000057 |
| 2024-10-02 | 11:03 ET | [8-K](/filings/0001682852-24-000052.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-24-000052 |
| 2024-09-12 | 10:03 ET | [8-K](/filings/0001682852-24-000049.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-24-000049 |
| 2024-08-01 | 20:02 ET | [10-Q](/filings/0001682852-24-000046.md) | Quarterly report, period 2024-06-30 | 0001682852-24-000046 |
| 2024-08-01 | 10:31 ET | [8-K](/filings/0001682852-24-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-24-000043 |
| 2024-07-23 | 11:05 ET | [8-K](/filings/0001682852-24-000035.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-24-000035 |
| 2024-05-09 | 21:58 ET | [8-K](/filings/0001682852-24-000031.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001682852-24-000031 |
| 2024-05-02 | 20:03 ET | [10-Q](/filings/0001682852-24-000027.md) | Quarterly report, period 2024-03-31 | 0001682852-24-000027 |
| 2024-05-02 | 10:31 ET | [8-K](/filings/0001682852-24-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-24-000023 |
| 2024-03-21 | 12:46 ET | [DEF 14A](/filings/0001308179-24-000208.md) | Proxy statement, period 2024-05-06 | 0001308179-24-000208 |
| 2024-02-23 | 21:03 ET | [10-K](/filings/0001682852-24-000015.md) | Annual report, period 2023-12-31 | 0001682852-24-000015 |
| 2024-02-22 | 11:32 ET | [8-K](/filings/0001682852-24-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-24-000010 |
| 2024-01-08 | 12:03 ET | [8-K](/filings/0001682852-24-000004.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-24-000004 |
| 2023-12-12 | 13:04 ET | [8-K](/filings/0001682852-23-000049.md) | 5.02 Departure or appointment of officers or directors | 0001682852-23-000049 |
| 2023-11-06 | 13:02 ET | [8-K](/filings/0001682852-23-000044.md) | 7.01 Regulation FD disclosure | 0001682852-23-000044 |
| 2023-11-03 | 20:02 ET | [10-Q](/filings/0001682852-23-000042.md) | Quarterly report, period 2023-09-30 | 0001682852-23-000042 |
| 2023-11-02 | 10:33 ET | [8-K](/filings/0001682852-23-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001682852-23-000038 |
| 2023-10-16 | 12:59 ET | [8-K](/filings/0001682852-23-000033.md) | 7.01 Regulation FD disclosure | 0001682852-23-000033 |
| 2023-09-11 | 12:08 ET | [8-K](/filings/0001682852-23-000030.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001682852-23-000030 |

Page 1 of 4. [Older](/companies/mrna/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.